Martin Glowacki, MD | |
6535 Rochester Rd, Suite 102, Troy, MI 48085-1362 | |
(248) 813-0060 | |
(248) 813-0066 |
Full Name | Martin Glowacki |
---|---|
Gender | Male |
Speciality | Interventional Pain Management |
Experience | 22 Years |
Location | 6535 Rochester Rd, Troy, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083716377 | NPI | - | NPPES |
MG080069 | Other | CHAMPUS-CHAMPUS | |
MG080069 | Other | COMMERCIAL-COMMERCIAL NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | 4301080069 (Michigan) | Primary |
207L00000X | Anesthesiology | 4301080069 (Michigan) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Providence - Crittenton Hospital Medical Center | Rochester, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sunrise Institute For Pain Management P.c. | 7911087465 | 2 |
News Archive
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
The A143T variant of the GLA gene is associated with an increased risk of Fabry cardiomyopathy, according to a new study.
Working at home has given many people the opportunity to arrange their working hours more freely than usual. But has it really given us more freedom?
› Verified 9 days ago
Entity Name | Sunrise Institute For Pain Management P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942496443 PECOS PAC ID: 7911087465 Enrollment ID: O20080109000521 |
News Archive
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
The A143T variant of the GLA gene is associated with an increased risk of Fabry cardiomyopathy, according to a new study.
Working at home has given many people the opportunity to arrange their working hours more freely than usual. But has it really given us more freedom?
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Martin Glowacki, MD 6535 Rochester Rd, Suite 102, Troy, MI 48085-1362 Ph: (248) 813-0060 | Martin Glowacki, MD 6535 Rochester Rd, Suite 102, Troy, MI 48085-1362 Ph: (248) 813-0060 |
News Archive
Talecris Biotherapeutics, Inc. announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in which low levels of the alpha(1) protein circulating in the lungs can increase an individual's risk of developing emphysema.
There is no evidence to back up claims that the new generation of anti-inflammatory drugs (COX-2 inhibitors) are less harmful to the stomach lining than many traditional anti-inflammatory drugs, concludes a study in the British Medical Journal.
The A143T variant of the GLA gene is associated with an increased risk of Fabry cardiomyopathy, according to a new study.
Working at home has given many people the opportunity to arrange their working hours more freely than usual. But has it really given us more freedom?
› Verified 9 days ago
Dr. Sean M Conroy, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 6535 Rochester Rd Ste 102, Troy, MI 48085 Phone: 248-813-0060 Fax: 248-813-0066 |